clenbuterol has been researched along with Atrophy, Muscle in 33 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We reported that clenbuterol (CB) induced masseter muscle hypertrophy and slow-to-fast myosin heavy chain (MHC) isoform transition through direct muscle β2-adrenergic receptor stimulation." | 3.81 | Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. ( Fujita, T; Mototani, Y; Nakamura, Y; Ohnuki, Y; Okumura, S; Saeki, Y; Shiozawa, K; Suita, K; Umeki, D, 2015) |
| "The effects of clenbuterol, a beta 2-adrenergic agonist, on body weight, tissue masses, and protein and RNA contents were studied following scald injury (30 per cent TBSA) in the rat." | 3.68 | Clenbuterol, a beta 2-adrenergic agonist, reverses muscle wasting due to scald injury in the rat. ( Fisher, MI; Little, RA; Martineau, L; Rothwell, NJ, 1993) |
| "The effects of a beta 2-adrenoceptor agonist, clenbuterol, on body weight and protein metabolism of gastrocnemius muscle, heart, and liver were studied in rats subjected to 50% food restriction or fasting." | 3.68 | Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat. ( Choo, JJ; Horan, MA; Little, RA; Rothwell, NJ, 1990) |
| "The attenuated muscle atrophy found with clenbuterol in the present study provides cellular evidence for the reported change in muscle strength after its administration after knee surgery." | 2.70 | Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats. ( Dykstra, DD; Herrera, NM; Thompson, LV; Zimmerman, AN, 2001) |
| "Uremic sarcopenia is caused by ageing, malnutrition, and chronic inflammation, but the molecular mechanism and potential therapeutics have not been fully elucidated yet." | 1.62 | β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice. ( Higashihara, T; Inagi, R; Maruyama, T; Nangaku, M; Nishi, H; Takemura, K; Tanaka, T; Watanabe, H, 2021) |
| "Clenbuterol has been used to alleviate chronic obstructive pulmonary disease and elicit an anabolic response in muscles." | 1.42 | Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats. ( Bisson, JF; Dernoncourt, V; Lang, G, 2015) |
| "Clenbuterol treatment induced growth by 27-41% in normal rats and attenuated muscle loss during hindlimb suspension by 10-20%." | 1.34 | Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. ( Bodine, SC; Kline, WO; Panaro, FJ; Yang, H, 2007) |
| "Clenbuterol has been shown to ameliorate denervation-induced atrophy and, therefore, clearly has therapeutic potential in the treatment of muscle wasting conditions in man." | 1.28 | Denervation increases clenbuterol sensitivity in muscle from young rats. ( Baillie, AG; Delday, MI; Hay, SM; Maltin, CA, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.09) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 13 (39.39) | 29.6817 |
| 2010's | 4 (12.12) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, D | 1 |
| Li, H | 1 |
| Yu, H | 1 |
| Zhao, M | 1 |
| Ye, L | 1 |
| Liu, B | 1 |
| Ge, N | 1 |
| Dong, N | 1 |
| Wu, L | 1 |
| Suzuki, H | 1 |
| Yoshikawa, Y | 1 |
| Tsujimoto, H | 1 |
| Kitaura, T | 1 |
| Muraoka, I | 1 |
| Higashihara, T | 1 |
| Nishi, H | 1 |
| Takemura, K | 1 |
| Watanabe, H | 1 |
| Maruyama, T | 1 |
| Inagi, R | 1 |
| Tanaka, T | 1 |
| Nangaku, M | 1 |
| Lang, G | 1 |
| Dernoncourt, V | 1 |
| Bisson, JF | 1 |
| Umeki, D | 1 |
| Ohnuki, Y | 1 |
| Mototani, Y | 1 |
| Shiozawa, K | 1 |
| Suita, K | 1 |
| Fujita, T | 1 |
| Nakamura, Y | 1 |
| Saeki, Y | 1 |
| Okumura, S | 1 |
| Cancelliero, KM | 1 |
| Durigan, JL | 1 |
| Vieira, RP | 1 |
| Silva, CA | 1 |
| Polacow, ML | 1 |
| Ung, RV | 1 |
| Rouleau, P | 1 |
| Guertin, PA | 1 |
| Gonçalves, DA | 1 |
| Silveira, WA | 1 |
| Lira, EC | 1 |
| Graça, FA | 1 |
| Paula-Gomes, S | 1 |
| Zanon, NM | 1 |
| Kettelhut, IC | 1 |
| Navegantes, LC | 1 |
| Dodd, SL | 2 |
| Koesterer, TJ | 1 |
| Agrawal, S | 1 |
| Thakur, P | 1 |
| Katoch, SS | 1 |
| Yimlamai, T | 1 |
| Borst, SE | 1 |
| Park, S | 1 |
| Hinkle, RT | 1 |
| Dolan, E | 1 |
| Cody, DB | 1 |
| Bauer, MB | 1 |
| Isfort, RJ | 1 |
| Kline, WO | 1 |
| Panaro, FJ | 1 |
| Yang, H | 1 |
| Bodine, SC | 1 |
| Martineau, L | 1 |
| Little, RA | 4 |
| Rothwell, NJ | 4 |
| Fisher, MI | 1 |
| Maltin, CA | 4 |
| Delday, MI | 4 |
| Watson, JS | 1 |
| Heys, SD | 1 |
| Nevison, IM | 1 |
| Ritchie, IK | 1 |
| Gibson, PH | 1 |
| Apseloff, G | 1 |
| Girten, B | 1 |
| Walker, M | 1 |
| Shepard, DR | 1 |
| Krecic, ME | 1 |
| Stern, LS | 1 |
| Gerber, N | 1 |
| Jiang, TX | 1 |
| Cairns, A | 1 |
| Road, JD | 1 |
| Wilcox, PG | 1 |
| Carbó, N | 1 |
| López-Soriano, J | 1 |
| Tarragó, T | 1 |
| González, O | 1 |
| Llovera, M | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Jiang, G | 1 |
| Gu, Y | 1 |
| Zhang, L | 1 |
| Ricart-Firinga, C | 1 |
| Stevens, L | 1 |
| Canu, MH | 1 |
| Nemirovskaya, TL | 1 |
| Mounier, Y | 1 |
| Sneddon, AA | 1 |
| Chen, KD | 1 |
| Alway, SE | 1 |
| Herrera, NM | 1 |
| Zimmerman, AN | 1 |
| Dykstra, DD | 1 |
| Thompson, LV | 1 |
| Cockman, MD | 1 |
| Jones, MB | 1 |
| Prenger, MC | 1 |
| Sheldon, RJ | 1 |
| Frerichs, O | 1 |
| Fansa, H | 1 |
| Ziems, P | 1 |
| Schneider, W | 1 |
| Keilhoff, G | 1 |
| Wineski, LE | 1 |
| von Deutsch, DA | 1 |
| Abukhalaf, IK | 1 |
| Pitts, SA | 1 |
| Potter, DE | 1 |
| Paulsen, DF | 1 |
| Agbenyega, ET | 1 |
| Wareham, AC | 1 |
| Hay, SM | 2 |
| Baillie, AG | 1 |
| Choo, JJ | 3 |
| Horan, MA | 3 |
| Wareham, A | 1 |
| Babij, P | 1 |
| Booth, FW | 1 |
| Reeds, PJ | 1 |
| Smith, FG | 1 |
| Lobley, GE | 1 |
3 trials available for clenbuterol and Atrophy, Muscle
| Article | Year |
|---|---|
Clenbuterol, a beta-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients.
Topics: Adult; Clenbuterol; Double-Blind Method; Humans; Knee Joint; Male; Menisci, Tibial; Muscle Contracti | 1993 |
[The effects of clenbuterol on intramuscular collagen metabolism in denervated muscle].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Arm; Brachial Plexus; Clenbuterol; Collagen; Denervatio | 1998 |
Clenbuterol in the prevention of muscle atrophy: a study of hindlimb-unweighted rats.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Clenbuterol; Hindlimb Suspension; Muscular | 2001 |
30 other studies available for clenbuterol and Atrophy, Muscle
| Article | Year |
|---|---|
Clenbuterol Prevents Mechanical Unloading-Induced Myocardial Atrophy via Upregulation of Transient Receptor Potential Channel-3.
Topics: Animals; Clenbuterol; Humans; Muscular Atrophy; Myocardium; Myocytes, Cardiac; Rats; Transient Recep | 2023 |
Clenbuterol accelerates recovery after immobilization-induced atrophy of rat hindlimb muscle.
Topics: Animals; Clenbuterol; Hindlimb Suspension; Male; Muscle Fibers, Skeletal; Muscular Atrophy; Rats; Ra | 2020 |
β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Ascorbic Acid; Cell Size; Clenbuterol; Female; Indican | 2021 |
Negative effect of clenbuterol on physical capacities and neuromuscular control of muscle atrophy in adult rats.
Topics: Analysis of Variance; Animals; Bronchodilator Agents; Clenbuterol; Disease Models, Animal; Explorato | 2015 |
Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Topics: Administration, Oral; Animals; Body Weight; Clenbuterol; Dexamethasone; Energy Metabolism; Feeding B | 2015 |
The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Connective Tissue; Glycogen; Immobilization; Male; M | 2008 |
Effects of co-administration of clenbuterol and testosterone propionate on skeletal muscle in paraplegic mice.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Androgens; Animals; Body Weight; Clenbuterol; Drug I | 2010 |
Clenbuterol suppresses proteasomal and lysosomal proteolysis and atrophy-related genes in denervated rat soleus muscles independently of Akt.
Topics: Adrenergic beta-Agonists; Animals; Cathepsin L; Clenbuterol; Cyclic AMP-Dependent Protein Kinases; E | 2012 |
Clenbuterol attenuates muscle atrophy and dysfunction in hindlimb-suspended rats.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium-Transporting ATPases; Clenbuterol; Disease M | 2002 |
Beta adrenoceptor agonists, clenbuterol, and isoproterenol retard denervation atrophy in rat gastrocnemius muscle: use of 3-methylhistidine as a marker of myofibrillar degeneration.
Topics: Acid Phosphatase; Adrenergic beta-Agonists; Alkaline Phosphatase; Amino Acids; Animals; Biomarkers; | 2003 |
Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway.
Topics: Administration, Oral; Animals; Clenbuterol; Female; Gene Expression Regulation; Hindlimb Suspension; | 2005 |
Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Analysis of Variance; Animals; Clenbu | 2005 |
Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Drug Interactions; Female; Hindlimb Suspension; Immu | 2007 |
Clenbuterol, a beta 2-adrenergic agonist, reverses muscle wasting due to scald injury in the rat.
Topics: Animals; Body Weight; Burns; Clenbuterol; Male; Muscles; Muscular Atrophy; Proteins; Rats; Rats, Spr | 1993 |
Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats.
Topics: Alendronate; Animals; Bone and Bones; Bone Density; Clenbuterol; Diphosphonates; Male; Muscles; Musc | 1993 |
Effect of the beta-agonist clenbuterol on dexamethasone-induced diaphragm dysfunction in rabbits.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Dexamethasone; Diaphragm; Female; Glucocorticoids; M | 1996 |
Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth.
Topics: Adipose Tissue; Adrenergic beta-Agonists; Albuterol; Animals; Body Weight; Cachexia; Clenbuterol; Ea | 1997 |
Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Calcium; Clenbuterol; Hindlimb Suspension; In Vitro | 2000 |
Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity.
Topics: Adrenergic beta-Agonists; Animals; Biological Transport; Clenbuterol; Denervation; Fluorescent Antib | 2000 |
A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
Topics: Adrenergic beta-Agonists; Aging; Animals; Body Weight; Clenbuterol; Isometric Contraction; Male; Mus | 2000 |
Magnetic resonance imaging of denervation-induced muscle atrophy: effects of clenbuterol in the rat.
Topics: Animals; Clenbuterol; Female; Magnetic Resonance Imaging; Muscle Denervation; Muscle, Skeletal; Musc | 2001 |
Regeneration of peripheral nerves after clenbuterol treatment in a rat model.
Topics: Animals; Cell Count; Clenbuterol; Disease Models, Animal; Male; Muscle Denervation; Muscle, Skeletal | 2001 |
Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Hindlimb Suspension; Humans; Male; Muscle, Skeletal; | 2002 |
Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone.
Topics: Animals; Clenbuterol; Dexamethasone; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; M | 1992 |
Denervation increases clenbuterol sensitivity in muscle from young rats.
Topics: Animals; Clenbuterol; Dose-Response Relationship, Drug; Heart; Male; Muscle Denervation; Muscles; Mu | 1992 |
Effects of the beta 2-adrenoceptor agonist, clenbuterol, on muscle atrophy due to food deprivation in the rat.
Topics: Adrenergic beta-Agonists; Animals; Body Weight; Clenbuterol; Ethanolamines; Fasting; Food Deprivatio | 1990 |
Anabolic beta-2-agonist clenbuterol fails to modify muscle atrophy due to femur fracture.
Topics: Adipose Tissue, Brown; Animals; Body Weight; Clenbuterol; Eating; Femoral Fractures; Male; Muscle Pr | 1990 |
Muscle wasting associated with endotoxemia in the rat: modification by the beta 2-adrenoceptor agonist clenbuterol.
Topics: Animals; Body Weight; Clenbuterol; Endotoxins; Ethanolamines; Male; Muscular Atrophy; Rats; Rats, In | 1989 |
Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle.
Topics: Actins; Animals; Body Weight; Clenbuterol; Cytochrome c Group; Denervation; Ethanolamines; Female; H | 1988 |
Inhibition and reversal of denervation-induced atrophy by the beta-agonist growth promoter, clenbuterol.
Topics: Animals; Clenbuterol; Ethanolamines; Glycolysis; Male; Muscle Contraction; Muscle Denervation; Muscl | 1986 |